Alkermes plc. Proceeds from Divestiture of Businesses, Net of Cash Divested
Alkermes plc. (ALKS) reported Proceeds from Divestiture of Businesses, Net of Cash Divested of -$15.00 million for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-07-28.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested · last filed 2018-02-16
- Alkermes plc. proceeds from divestiture of businesses, net of cash divested for the quarter ending 2015-12-31 was -$301.00K.
- Alkermes plc. proceeds from divestiture of businesses, net of cash divested for the quarter ending 2015-09-30 was $26.00K.
- Alkermes plc. proceeds from divestiture of businesses, net of cash divested for fiscal 2015 was $49.97M.
| Period end | Proceeds from Divestiture of Businesses, Net of Cash Divested 3 month | Proceeds from Divestiture of Businesses, Net of Cash Divested 6 month | Proceeds from Divestiture of Businesses, Net of Cash Divested 9 month | Proceeds from Divestiture of Businesses, Net of Cash Divested 12 month |
|---|---|---|---|---|
| 2016-06-30 | -$15.00M 10-Q · filed 2016-07-28 | |||
| 2015-12-31 | -$301.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | -$275.00K derived: sum of 2 quarters · filed 2018-02-16 | $49.97M 10-K · filed 2018-02-16 | |
| 2015-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $50.27M 10-Q · filed 2016-11-02 | ||
| 2015-06-30 | $50.24M 10-Q · filed 2015-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |